Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Hepatocellular Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Gustave Roussy, Villejuif, France
Contact: Study coordinator (Lambros Tselikas, MD) · lambros.tselikas@gustaveroussy.fr · +33 (0)1 42 11 42 11

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma · HCC

Abroad (travel likely)RecruitingPHASE2

Orange, United States

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Los Angeles, United States

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Gastroesophageal Cancer (GC) · Hepatocellular Carcinoma (HCC) · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1

Boston, United States · Omaha, United States

A Study of MGC026 in Participants With Advanced Solid Tumors

Advanced Solid Tumor · Advanced Cancer · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Grand Rapids, United States